Globus Medical (GMED) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Globus Medical (GMED) has a cash flow conversion efficiency ratio of 0.043x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($202.36 Million) by net assets ($4.73 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Globus Medical to measure how much of total assets are equity-financed.
Globus Medical - Cash Flow Conversion Efficiency Trend (2010–2025)
This chart illustrates how Globus Medical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check GMED operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Globus Medical Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Globus Medical ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CITIC Securities Company Limited
F:CI9
|
0.221x |
|
ALSTOM S.A. UNSP.ADR 1/10
F:AOMU
|
N/A |
|
Leader Harmonious Drive Systems Co Ltd
SHG:688017
|
0.022x |
|
Agree Realty Corporation
NYSE:ADC
|
0.023x |
|
Nuvalent Inc
NASDAQ:NUVL
|
-0.079x |
|
Storebrand ASA
OL:STB
|
0.363x |
|
FirstCash Inc
NASDAQ:FCFS
|
0.067x |
|
Tianshan Aluminum Group Co Ltd
SHE:002532
|
0.050x |
Annual Cash Flow Conversion Efficiency for Globus Medical (2010–2025)
The table below shows the annual cash flow conversion efficiency of Globus Medical from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see Globus Medical market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $4.57 Billion | $753.45 Million | 0.165x | +32.19% |
| 2024-12-31 | $4.18 Billion | $520.64 Million | 0.125x | +104.63% |
| 2023-12-31 | $4.00 Billion | $243.50 Million | 0.061x | -36.99% |
| 2022-12-31 | $1.85 Billion | $178.47 Million | 0.097x | -39.07% |
| 2021-12-31 | $1.74 Billion | $276.27 Million | 0.159x | +20.21% |
| 2020-12-31 | $1.51 Billion | $198.79 Million | 0.132x | +7.63% |
| 2019-12-31 | $1.40 Billion | $171.97 Million | 0.123x | -19.97% |
| 2018-12-31 | $1.19 Billion | $181.64 Million | 0.153x | -7.05% |
| 2017-12-31 | $967.78 Million | $159.53 Million | 0.165x | -20.20% |
| 2016-12-31 | $832.08 Million | $171.89 Million | 0.207x | +21.17% |
| 2015-12-31 | $715.32 Million | $121.96 Million | 0.170x | +26.07% |
| 2014-12-31 | $585.45 Million | $79.17 Million | 0.135x | -31.66% |
| 2013-12-31 | $472.36 Million | $93.47 Million | 0.198x | -0.05% |
| 2012-12-31 | $386.50 Million | $76.52 Million | 0.198x | -26.81% |
| 2011-12-31 | $282.48 Million | $76.41 Million | 0.271x | -13.41% |
| 2010-12-31 | $228.19 Million | $71.29 Million | 0.312x | -- |
About Globus Medical
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting… Read more